EBITDA increase for MedicX

MedicX Fund Ltd, the specialist primary care infrastructure investor, announced last month that EBITDA grew 39.6% to £12.6m for the year ending 30 September 2012. Total income hit £20.6m (2011: £12.6m) while spending including acquisitions increased to £21.8m from the £8.8m expended in 2011. This led to a loss before tax of £1.1m – however the organisation was still in receipt of an operating profit of £2.5m (2011: £3.7).